子宫内膜异位症妇女腹腔液中微小RNA谱与蛋白质及其与不育的关系
病例对照研究纳入126例子宫内膜异位症妇女(EPF)和45例对照妇女(CPF),用miRNA芯片和qRT-PCR验证9个miRNA,并用ELISA和MILLIPLEX检测腹腔液中多种细胞因子与蛋白。结果显示EPF中miR-106b-3p、miR-451a、miR-486-5p及IL-6、IL-8、uPA、TIMP-1水平升高,月经期EPF多种miRNA和蛋白上调而CPF无此变化。作者认为miRNA可能参与子宫内膜异位症的腹膜改变,并可能作为预测生育结局的生物标志物。
要点
- EPF中miR-106b-3p、miR-451a、miR-486-5p及IL-6、IL-8、uPA、TIMP-1水平高于CPF。
- 月经期EPF中miR-106b-3p、miR-130a-3p、miR-150-5p、miR-185-5p、miR-451a、miR-486-5p及VEGF-A、IL-8、MIP1β、uPA、PAI-1上调,CPF无此变化。
- 不育EPF中miR-486-5p较不育CPF上调,不育和可育EPF中VEGF-A、IL-8、TIMP-1较可育CPF升高。
核心结论
- miRNA似乎参与子宫内膜异位症的腹膜改变,提示异位病灶植入的新机制,并可能作为预测生育结局的生物标志物。
研究设计与样本
- 病例对照研究,纳入126例子宫内膜异位症妇女(EPF)和45例对照妇女(CPF)。
- 从6例EPF和6例CPF制备miRNA芯片,并对9个选定miRNA进行qRT-PCR验证。
- 用ELISA和MILLIPLEX定量检测腹腔液中VEGF-A、TSP-1、uPA、PAI-1、MMP3、TIMP-1、IL-6、IL-8、IL-17A、MIP1β、PDGF-AA和RANTES。
主要发现
- miRNA芯片显示EPF中126个miRNA差异表达(倍数变化±1.2),其中78个下调、48个上调。
- 验证显示EPF中miR-106b-3p、miR-451a、miR-486-5p及IL-6、IL-8、uPA、TIMP-1水平高于CPF。
- 月经期EPF中miR-106b-3p、miR-130a-3p、miR-150-5p、miR-185-5p、miR-451a、miR-486-5p及VEGF-A、IL-8、MIP1β、uPA、PAI-1较其他期别上调,而CPF无此变化。
- 不育EPF中miR-486-5p较不育CPF上调,不育和可育EPF中VEGF-A、IL-8、TIMP-1较可育CPF升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To define the microRNA (miRNA) profile and its relationship with cytokines content in peritoneal fluid (PF) from endometriosis patients. DESIGN: Case-control study. SETTING: University hospital, research institute. PATIENT(S): One hundred twenty-six women with endometriosis (EPF) and 45 control women (CPF). MAIN OUTCOMES MEASURE(S): MiRNA arrays were prepared from six EPF and six CPF. Quantitative reverse transcription-polymerase chain reaction validation of nine selected miRNAs (miR-29c-3p, -106b-3p, -130a-3p, -150-5p, -185-5p, -195-5p, -451a, -486-5p, and -1343-5p) was performed. Vascular endothelial growth factor-A (VEGF-A), thrombospondin-1 (TSP-1), urokinase plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), matrix metalloproteinase-3 (MMP3), tissue inhibitor of metalloproteinases type 1 (TIMP-1), interleukin (IL)-6, IL-8, IL-17A, macrophage inflammatory protein 1β (MIP1beta), platelet-derived growth factor α-polypeptide A, and regulated on activation, normal T cell expressed and secreted (RANTES) were quantified by ELISA and MILLIPLEX. RESULT(S): MiRNA arrays showed 126 miRNAs differentially expressed (fold change ±1.2) (78 down-regulated, 48 up-regulated) in EPF. Validation showed higher levels of miR-106b-3p, -451a, -486-5p, IL-6, IL-8, uPA, and TIMP-1 in EPF. In menstrual phase, EPF presented up-regulation of miR-106b-3p, -130a-3p, -150-5p, -185-5p, -451a, -486-5p, VEGF-A, IL-8, MIF 1β, uPA, and PAI-1 compared with other phases; however, CPF did not. MiRNA-486-5p was up-regulated in sterile EPF compared with sterile controls, and VEGF-A, IL-8, and TIMP-1 were increased in sterile and fertile EPF compared with fertile CPF. CONCLUSION(S): MiRNAs seem to be involved in the peritoneal alterations in endometriosis, suggesting new mechanisms by which ectopic lesions could implant in endometriosis patients; and to serve as biomarkers for fertility outcome prediction.
引用
- Marí-Alexandre J, Barceló-Molina M, Belmonte-López E, et al. Micro-RNA profile and proteins in peritoneal fluid from women with endometriosis: their relationship with sterility. Fertil Steril. 2018. PMID: 29605406. doi:10.1016/j.fertnstert.2017.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。